Treatment failure | Objective response or TTF > 4monts | Healthy controls | ||
---|---|---|---|---|
FGF2 (pg/ml) | N | 5 | 7 | 8 |
median | 3.4 | 1.8 | 0.8 | |
range | (1.9-23.7) | (0.4-14.8) | (0.2-2.3) | |
p-value | 0.02* | |||
IL8 (pg/ml) | N | 5 | 7 | 8 |
median | 27.2 | 5.8 | 5.8 | |
range | (12.2-61.9) | (2.8-18.9) | (1.1-7.5) | |
p-value | 0.006** | |||
TSP-1 (ng/ml) | N | 5 | 7 | 8 |
median | 125.1 | 69.6 | 67.3 | |
range | (85.1-328.4) | (24-452) | (9-710.1) | |
p-value | 0.047 | |||
VEGF (pg/ml) | N | 5 | 7 | 10 |
median | 1552 | 428,6 | 2094 | |
range | (804.3-2785) | (252.4-3116) | (1122-2387) | |
p-value | 0.074 | |||
VEGFR-2 (pg/ml) | N | 5 | 7 | 8 |
median | 13680 | 13275 | 12328 | |
range | (8945-16465) | (7455-18065) | (8235-17615) | |
p-value | 0.657 |